Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
94.91
+4.91 (5.46%)
At close: Apr 14, 2026, 4:00 PM EDT
94.02
-0.89 (-0.94%)
After-hours: Apr 14, 2026, 6:14 PM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $5.02 billion as of April 14, 2026. Its market cap has increased by 682.45% in one year.
Market Cap
5.02B
Enterprise Value
4.48B
1-Year Change
682.45%
Ranking
Category
Stock Price
$94.91
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $5.02B, an increase of 2,982.76%. That is a compound annual growth rate of 275.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 5.02B | 184.38% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 5.57B |
| Erasca | 5.29B |
| Apellis Pharmaceuticals | 5.21B |
| Caris Life Sciences | 5.10B |
| Immunovant | 4.99B |
| TG Therapeutics | 4.98B |
| CRISPR Therapeutics AG | 4.92B |
| Amicus Therapeutics | 4.54B |